Contact us

Our People

Meet our experienced team of leaders and scientific experts.

The leadership team all have several decades of big pharma industrial experience and have been responsible for delivering numerous products through development to launch while our experienced team of scientists are all experts in their chosen field. If you wish to contact any of our team with a specific question or enquiry you can do so below and they will be happy to help. Expect a reply typically within 48 hours.

View our team by expertise

SELECT EXPERTISE

  • All Expertise
  • Oral Drug Delivery
  • DMPK and Dose Selection
  • Pharmacokinetic Modelling
  • Complex Medicines
  • Paediatric Product Development
  • Regulatory CMC
  • Clinical Pharmacology
  • Analytical Sciences
  • Chemical Development

Leadership Team

Expertise:

  • Oral Drug Delivery
  • Complex Medicines
  • Paediatric Product Development
  • Regulatory CMC

Paul W Stott

BPharm (Hons) PhD

Director & CEO

Paul W Stott

BPharm (Hons) PhD

Director & CEO

View Bio Ask me a question

Paul is an established pharma executive with extensive global experience. Prior to joining Seda he was Vice President, Global Product Development at AstraZeneca, leading a group of over 350 scientists and engineers in the development of all products, manufacturing processes and analytical methods for the AstraZeneca small molecule portfolio.

AstraZeneca Global Product Development has centres in the UK, Sweden, US and China and a network of partnerships with colleagues all over the world and under Paul’s stewardship registered 10 global products.

At AstraZeneca Paul was accountable for the Drug Product CMC component of all Due Diligence assessments and was CMC lead on several multibillion dollar acquisitions. In addition, Paul is a visiting Professor of Pharmaceutics at the University of Manchester, UK and founder of the North West Centre for Drug Delivery (NoWCADD) at the University.

He is a proven senior manager and strategic leader in Pharmaceutical Development with experience across geographical boundaries. Passionate about the development of individual and group capabilities and the application of innovation and scientific rigour to bring new medicinal products to market.

He is recognised within the Industry and with Regulatory Agencies as a driving force in the establishment and realisation of best practice in CMC Quality by Design.

Ask me a question

    Expect a reply typically within 48 hours.

    Expertise:

    • DMPK and Dose Selection
    • Pharmacokinetic Modelling
    • Complex Medicines
    • Regulatory CMC
    • Clinical Pharmacology

    Paul A Dickinson

    BPharm (Hons) PhD

    Director & Co-Founder

    Paul A Dickinson

    BPharm (Hons) PhD

    Director & Co-Founder

    View Bio Ask me a question

    Paul has held several senior science leadership roles in Academia and Large Pharma.  These roles focused on applying the best science in projects to ensure optimal product performance in the patient, thus bridging pharmaceutical and clinical disciplines.

     

    Immediately prior to founding Seda Pharmaceutical Development Services Paul was Senior Clinical Pharmacology Scientist at AstraZeneca and led the clinical pharmacology program to NDA/MAA for AZD9291/osimertinib, which had been awarded ‘breakthrough therapy’ status by the FDA.  Formerly Paul was a Principal Scientist within Pharmaceutical Development (AZ) leading both the global biopharmaceutics network and the Medicines Evaluation science community (USA, SE, UK).

     

    Paul has been at the forefront of recent advances in the understanding of in vitro performance criteria that assure product performance in the patient including clinically relevant dissolution specifications (CRDS).  Paul has co-authored papers with FDA staff focussed on efforts to combine biopharmaceutics with ICH Q8 (BioRAM) and is past Chair of the AAPS ‘QbD and product performance’ focus group.

     

    Ask me a question

      Expect a reply typically within 48 hours.

      Expertise:

      • Oral Drug Delivery
      • Complex Medicines
      • Paediatric Product Development
      • Regulatory CMC
      • Analytical Sciences

      Marcel de Matas

      BSc (Hons) PhD FRSC CChem

      Director & Co-Founder

      Marcel de Matas

      BSc (Hons) PhD FRSC CChem

      Director & Co-Founder

      View Bio Ask me a question

      Marcel has a track record in a range of management and senior scientific positions in industry and academia. Most recently he was a Principal Scientist in Product Design and Innovation at AstraZeneca, where he was responsible for introducing the latest science, new technologies (advanced drug delivery and manufacturing) and product design thinking into the Product Development group.

      Marcel has led technical activities, provided project leadership and has managed product development teams responsible for the delivery of drug projects from initial concept design through late stage development, regulatory submission and launch (including advanced drug delivery systems). He has led teams at the drug discovery-development interface, assessing the level of chemistry manufacturing and controls (CMC) technical risk and defining product design strategies in early development. Project experience has covered projects across a range of disease and therapy areas with substantial experience in the oncology field.

      Ask me a question

        Expect a reply typically within 48 hours.

        Our Team

        Expertise:

        • Complex Medicines

        Fanny Joubert

        BSc (Hons) PhD

        Senior Scientist

        Fanny Joubert

        BSc (Hons) PhD

        Senior Scientist

        View Bio Ask me a question

        Fanny has a strong educational training with a bachelor’s degree in chemistry followed by an engineer diploma in Materials Science and finally a PhD in Polymer Chemistry. Following her studies, she has worked as a Research Associate for 6+ years in both Academia and large Pharma focussing on polymers for healthcare and precision nanomedicine applications. She joined Seda as Senior Scientist to facilitate the development of complex parenterals using her knowledge of Nanotechnology.

        Ask me a question

          Expect a reply typically within 48 hours.

          Expertise:

          • Oral Drug Delivery
          • DMPK and Dose Selection
          • Pharmacokinetic Modelling

          Linette Ruston

          BSc (Hons) PhD

          Senior Principal Scientist: ADME

          Linette Ruston

          BSc (Hons) PhD

          Senior Principal Scientist: ADME

          View Bio Ask me a question

          Linette is a Senior Principal Scientist at Seda with a BSc (Hons) and PhD in Chemistry from Universities of Glasgow and Edinburgh, respectively.  She is an experienced Biopharmaceutics and DMPK scientist having spent 17+ years with AstraZeneca where she held roles in Discovery and Early Pharmaceutical Development, providing expert physicochemical, ADME and Biopharmaceutics input into compound design and selection, and applied knowledge of in vitro, in silico and in vivo models to enable material choice and project progression from discovery to early clinical development.  Her current focus is on translation of DMPK/PD and biopharmaceutics understanding into meaningful product and clinical study design within Seda.

          Ask me a question

            Expect a reply typically within 48 hours.

            Expertise:

            • Pharmacokinetic Modelling

            Jake Dickinson

            BSc (Hons)

            Senior Modeller

            Jake Dickinson

            BSc (Hons)

            Senior Modeller

            View Bio Ask me a question

            A physics graduate, with over 3 years’ experience in the pharmaceutical industry. Jake has applied analytical, mathematical, and problem-solving skills to the assessment of the likelihood of drug candidate success and to identify the likely risks involved in the formulation of a drug. Areas of expertise include PK / PK-PD-TGI modelling in preclinical species and translation to man to aid in dose prediction. Jake has developed models and applications including Nora Max, an in silico absorption model, that aids decision making in late preclinical and early clinical drug development phases of drug development and enables the identification of the formulation technologies required for FiH.

            Ask me a question

              Expect a reply typically within 48 hours.

              Expertise:

              • Oral Drug Delivery
              • Paediatric Product Development
              • Complex Medicines

              Shanoo Buhdheo

              BSc (Hons)

              Principal Scientist

              Shanoo Buhdheo

              BSc (Hons)

              Principal Scientist

              View Bio Ask me a question

              Shanoo is an experienced pharmaceutical development scientist with many years’ experience in large pharma and the biotech sector. She has a particular interest in biopharmaceutics, development of clinically relevant in vitro tests and the development of products for paediatrics.

              Ask me a question

                Expect a reply typically within 48 hours.

                Expertise:

                • Complex Medicines
                • Pharmacokinetic Modelling
                • Clinical Pharmacology

                Claire Patterson

                MPharm (Hons) PhD

                Senior Principal Scientist

                Claire Patterson

                MPharm (Hons) PhD

                Senior Principal Scientist

                View Bio Ask me a question

                Claire Patterson is Senior Principal Scientist at Seda with a Master of Pharmacy (MPharm) and a Ph.D. in Pharmaceutics from the Universities of Nottingham and University College London respectively. Claire is an experienced Biopharmaceutics scientist having spent 12 years with former employer AstraZeneca with roles in Early and Late Stage Product Development, linking in vitro to in vivo product performance. Current focus areas include subcutaneous and complex parenteral biopharmaceutics (including nanomedicines) and other non-oral routes of administration.

                Ask me a question

                  Expect a reply typically within 48 hours.

                  Expertise:

                  • Oral Drug Delivery
                  • Complex Medicines
                  • Regulatory CMC

                  Nicola Parisi

                  MSc PhD

                  Principal Scientist

                  Nicola Parisi

                  MSc PhD

                  Principal Scientist

                  View Bio Ask me a question

                  Nicola holds a MSc in Pharmaceutical Chemistry from the University of Messina and a PhD in Pharmaceutics from UCL School of Pharmacy. He is an accomplished Formulation Scientist with 9+ years’ experience in the field and roles at AstraZeneca and GlaxoSmithKline. He additionally holds a qualification from the Association for Project Management (PFQ). He is expert in planning, leading and managing clinical drug product development projects and has a deep understanding of change control, risk and stakeholder management processes.

                  Ask me a question

                    Expect a reply typically within 48 hours.

                    Expertise:

                    • Analytical Sciences

                    Joanna Denbigh

                    MChem PhD

                    Principal Scientist

                    Joanna Denbigh

                    MChem PhD

                    Principal Scientist

                    View Bio Ask me a question

                    Jo is an experienced Analytical Chemist (16+ years) with a Masters  degree in Analytical Chemistry (MChem) from the University of Salford and PhD in Bioanalytical Chemistry from the University of Manchester. She has an accomplished track record in both industrial (GSK, Waters, Thermofisher) and academic sectors globally, with specialisms in Chromatography, Mass Spectrometry and Infrared & Raman spectroscopies across a wide range of challenging pharmaceutical and biological applications. Jo is an experienced project manager and works collaboratively with partners in both academia and industry to facilitate progress in the field.

                    Ask me a question

                      Expect a reply typically within 48 hours.

                      Expertise:

                      • DMPK and Dose Selection
                      • Oral Drug Delivery
                      • Complex Medicines
                      • Pharmacokinetic Modelling
                      • Clinical Pharmacology

                      Wang Wang Lee

                      MPharm (Hons) PhD GPhC

                      Principal Scientist

                      Wang Wang Lee

                      MPharm (Hons) PhD GPhC

                      Principal Scientist

                      View Bio Ask me a question

                      Wang Wang Lee is a GPhC registered pharmacist with a PhD in Pharmaceutical Sciences and MBA from the University of Strathclyde. She has deep industry and academic experience particularly in the areas of biopharmaceutics and product development. Her expertise in early and late stage development, risk assessing and mitigating the development challenges has helped clients transition compounds into the clinic from discovery. Most recently, she is interested in DMPK and clinical pharmacology projects for poorly solubles and complex parenterals.

                      Ask me a question

                        Expect a reply typically within 48 hours.

                        Expertise:

                        • Chemical Development
                        • Regulatory CMC

                        Bill Moss

                        BSc (Hons) PhD

                        Consultant - Chem. Dev.

                        Bill Moss

                        BSc (Hons) PhD

                        Consultant - Chem. Dev.

                        View Bio Ask me a question

                        Dr Bill Moss has over 25 years’ experience as a scientist and leader working in the following areas:

                        • Chemical Development and manufacture of clinical and commercial drug substance
                        • Expertise in the Discovery interface, Preclinical and Phase1/Phase II development, supporting the progression of new candidate drugs from discovery into development
                        • Drug substance project strategy development and integration with drug product, safety and clinical planning
                        • Extensive experience of outsourcing drug substance development and manufacture
                        • Authoring and reviewing regulatory submissions from Phase I to marketing submissions

                        Ask me a question

                          Expect a reply typically within 48 hours.

                          Expertise:

                          • Analytical Sciences
                          • Regulatory CMC

                          Peter Doyle

                          BSc (Hons) MSc PhD

                          Consultant - Analytical Sci.

                          Peter Doyle

                          BSc (Hons) MSc PhD

                          Consultant - Analytical Sci.

                          View Bio Ask me a question

                          Peter has worked in the pharmaceutical and healthcare sector for over 25 years with leadership and scientific positions at J&J, AstraZeneca and Glaxo. He has extensive experience in the management of outsourced projects with a focus on analytical development activities. Peter has authored many regulatory submissions from FiH to NDA / MAA and has an expert understanding of the regulatory requirements at each stage of development. He has been a consultant to the biotech sector since 2017.

                          Ask me a question

                            Expect a reply typically within 48 hours.

                            Expertise:

                            • Oral Drug Delivery
                            • Complex Medicines

                            Talbir Austin

                            BSc (Hons) PhD CChem MRSC

                            Consultant - Material Sciences

                            Talbir Austin

                            BSc (Hons) PhD CChem MRSC

                            Consultant - Material Sciences

                            View Bio Ask me a question

                            Dr Talbir (Tal) Austin is a consultant providing expertise in solid state, material design and characterisation, and development with particular focus on the early development phase.

                            Dr Austin is a structural organic chemist who has worked within the pharmaceutical industry for nearly three decades. Her previous positions involved complex problem solving and troubleshooting of projects – overseeing material design, selection and development, from the Preclinical phase through to Early Development at AstraZeneca. She also led the design and implementation of AstraZeneca’s material selection strategy at the discovery and development interface. Dr Austin has extensive experience in optimising material properties for different therapy areas (Respiratory, Inflammation, CNS, CV, GI and Oncology) and modes of administration; oral, inhalation, parenteral, topical.

                            Ask me a question

                              Expect a reply typically within 48 hours.

                              Expertise:

                              • Regulatory CMC

                              Roy Jamieson

                              BPharm (Hons)

                              Consultant - Regulatory CMC

                              Roy Jamieson

                              BPharm (Hons)

                              Consultant - Regulatory CMC

                              View Bio Ask me a question

                              Roy is an experienced Pharma Industry & Regulatory CMC professional having spent time as a quality assessor at MHRA and with over 25 years in large pharma organisations leading numerous small molecule projects from FTiH through Marketing Authorisation and launch. As an Independent Consultant he has worked with many small companies as well as collaborating with consultancy firms and is currently supporting the South African Agency (SAHPRA) as a Quality/CMC reviewer supporting their generic backlog programme.

                              Roy has successfully led 4 major global submissions through Phase 3 to marketing authorisation approval. His key area of regulatory scientific expertise and interest centres on biopharmaceutics aspects of solid oral dosage forms of small molecules and the bridge between quality performance and the pharmacokinetic profile linked to safety and efficacy.

                              Ask me a question

                                Expect a reply typically within 48 hours.

                                Expertise:

                                • Pharmacokinetic Modelling

                                Parmesh Gajjar

                                BA (Hons) MMath PhD

                                Principal Scientist

                                Parmesh Gajjar

                                BA (Hons) MMath PhD

                                Principal Scientist

                                View Bio Ask me a question

                                Parmesh has a strong mathematical background with a BA (Hons) & MMath from the University of Cambridge and a PhD in Applied Mathematics from the University of Manchester. He has 5 years of pharmaceutical experience working on the physical characterisation of inhalation medicines, working alongside large Pharma and Contract Drug Manufacturing Organisations (CDMOs). At SEDA, he will be applying his problem-solving ability to pharmacokinetic and pharmacodynamic modelling.

                                Ask me a question

                                  Expect a reply typically within 48 hours.

                                  Expertise:

                                  • Complex Medicines
                                  • Oral Drug Delivery

                                  Alexander Clout

                                  BSc (Hons) PhD

                                  Senior Scientist

                                  Alexander Clout

                                  BSc (Hons) PhD

                                  Senior Scientist

                                  Alex has a background in chemistry and holds a PhD in pharmaceutics from University College London, during which he gained extensive experience in the solid-state characterisation of pharmaceutical materials, including polymorphism and co-crystallisation, combining both thermal and structural analyses to develop a full picture of the changes occurring when materials undergo phase transitions. More recently he has worked on projects in formulation development with a particular focus on the microfluidic manufacture of nanomaterials for administration of sustained release parenterals. He also has valuable experience in the development and manufacture of oral solid dosage forms.

                                  Expertise:

                                  • Pharmacokinetic Modelling

                                  Harri Dickinson

                                  BSc (Hons)

                                  Modeller

                                  Harri Dickinson

                                  BSc (Hons)

                                  Modeller

                                  Harri is able to apply commercially available software PK-Sim, in order to form translational PB-PK modelling for different species or populations and help with dose selection in the early clinical stage settings. As a Mathematics graduate his background enables him to bring systems thinking to PK modelling to identify sources of uncertainty and risk.

                                  Expertise:

                                  • Analytical Sciences

                                  Alan Raoof

                                  BSc MSc

                                  Scientist

                                  Alan Raoof

                                  BSc MSc

                                  Scientist

                                  Alan is an overseas Pharmacist with 9 years’ experience in the pharmacy environment. He has an MSc degree with distinction in Drug Design and Discovery from the University of Salford, and another MSc in Pharmaceutical Analysis from the University of Strathclyde. Alan has experience working as a QC analyst for almost 2 years in a GMP environment, and has worked for 2 years as an assistant lecturer in the School of Pharmacy at University of Sulaimani. He has special interests in characterisation of pharmaceutical materials, nanomedicines, analytical method development and utilising spectroscopy and chromatography in chemical and bioanalysis.

                                  Expertise:

                                  • Oral Drug Delivery
                                  • Complex Medicines

                                  Elen Roberts

                                  BSc (Hons)

                                  Scientist

                                  Elen Roberts

                                  BSc (Hons)

                                  Scientist

                                  First class Medical Science graduate with 1.5 years experience working in the pharmaceutical industry. Areas of focus include formulation development for both preclinical and clinical studies across a range of administrative routes and indications, including the use of amorphous solid dispersions to enhance the solubility of poorly soluble compounds.

                                  Lorraine Jones

                                  BSc (Hons)

                                  Scientist

                                  Lorraine Jones

                                  BSc (Hons)

                                  Scientist

                                  Lorraine has over 20 years’ high quality laboratory experience at a leading global pharmaceutical company and one of the world’s leading toxicology laboratories. She is experienced in most aspects of drug development and toxicology, ranging from pre-clinical toxicology through to human clinical trials.

                                  Expertise:

                                  • Oral Drug Delivery
                                  • Analytical Sciences

                                  Sin Nee Teoh

                                  BSc (Hons) MRes

                                  Scientist

                                  Sin Nee Teoh

                                  BSc (Hons) MRes

                                  Scientist

                                  Sin Nee has a Medicine and tissue engineering background with 1.5 years’ experience working in the pharmaceutical industry. Areas of experience include formulation development for preclinical and clinical studies as well as analytical development for Client specific compounds. Responsible for method development and upkeep of LC systems in Seda.

                                  Expertise:

                                  • Oral Drug Delivery
                                  • Analytical Sciences

                                  Vivien Lin

                                  BSc (Hons) MRes

                                  Scientist

                                  Vivien Lin

                                  BSc (Hons) MRes

                                  Scientist

                                  Biomaterial and tissue engineering graduate with a MRes in regenerative medicine. Working in the pharmaceutical industry for 1 year. Focus on analytical and formulation development for both preclinical and clinical studies.

                                  Kati de Matas

                                  BSc (Hons)

                                  Business Administrator

                                  Kati de Matas

                                  BSc (Hons)

                                  Business Administrator

                                  Kati is a first-class maths graduate from Keele University and has 1.5 years’ experience working for a marketing and advertising agency. With a mathematical background, she has a particular interest in finance management and accounting. Kati provides support within all areas of the business, to enhance efficiency and productivity, including procurement, finance management and marketing.